Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05659056
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2022-12-02
Brief Title:
Neoadjuvant Study With Pyrotinib and Trastuzumab and Abraxane in Patients With HER2-enriched Breast Cancer
Sponsor:
Organization:
The First Affiliated Hospital with Nanjing Medical University